TB Research

A Miracle Drug for Tuberculosis: Bedaquiline

Renuka Kandasamy, Subakeerthi Venkataramanan

Pondicherry Journal of Nursing · 2021-03

Abstract

A new tuberculosis (TB) medication includes the active ingredient bedaquiline. Sirturo is a brand name for a drug that belongs to the diarylquinoline class of drugs. Bedaquiline is a diarylquinoline antimycobacterial drug that works by blocking an enzyme within the bacteria that cause TB. It prevents the proton pump of mycobacterial adenosine 5-triphosphate (ATP) synthase. Bedaquiline is metabolized in hepatic form and eliminated in the feces. Bedaquiline is effective and safe in treating multidrug-resistant tuberculosis (MDR-TB) and extensively drugresistant tuberculosis (XDR-TB) patients. This drug treatment regimen was well supported and tended to a good result in this clinically relevant patient associated with MDR-TB.

MeSH terms

  • Bedaquiline
  • Miracle
  • Tuberculosis
  • Drug
  • Medicine